D-1033-2018 Class III Terminated

Recalled by Renaissance Lakewood, LLC — Lakewood, NJ

FDA drug recall D-1033-2018 was initiated by Renaissance Lakewood, LLC on Jul 11, 2018 and is designated Class III. Reason for recall: Superpotent Drug: lots out of specification for elevated sodium chloride and fluconazole assay. The recall status is terminated (terminated Mar 9, 2022). Affected quantity: 12088 bags.

Recall details

Product Type
Drugs
Report Date
Aug 8, 2018
Initiation Date
Jul 11, 2018
Termination Date
Mar 9, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12088 bags

Product description

Fluconazole Injection, USP, Iso-Osmotic Sodium Chloride Diluent, 200 mg in 100 mL (2 mg/mL), 100 mL Single Dose Flexible Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India, NDC a) 36000-002-10 and b) 36000-002-06.

Reason for recall

Superpotent Drug: lots out of specification for elevated sodium chloride and fluconazole assay.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: a) A060966, A060967, A060965, A061023, Exp 07/18; b) A060962, Exp 02/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1033-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1033-2018. Report a data issue: hello@regdatalab.com.